Diasome Pharmaceuticals (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- July 06, 2017
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $30,000,000
Company Info
- Founders
- Robert Geho
- Company Description
- Diasome Pharmaceuticals is a clinical stage biopharmaceutical company focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company's pipeline includes novel, proprietary liver targeted insulins for both Type 1 and Type 2 diabetes patients that are currently being tested in multiple human clinical trials.
- Market
- Diabetes and Obesity
- Location
- Cleveland, Ohio, USA
- Coinvestors
- Black Beret Life Sciences, JDRF T1D Fund, McDonald Partners, Medicxi